Skip to main content
Home
  • Home
  • About
    • Who We Are
    • History
    • Governance
      • Board of Members
      • Board of Directors
      • Executive Management
      • Senior Management
    • Principal Investigators
    • Our Capacity
    • Partners
    • Collaborators
    • Sponsors
    • Careers
    • Tenders
  • Research
    • Research Themes
    • Studies
      • Ongoing Studies
      • Completed Studies
    • Laboratory
    • Pharmacy
    • Clinical Research Sites
    • Data Management
    • Regulatory
    • Publications
  • Capacity Building
    • Training
    • Projects
  • Community Engagement
    • Community Engagement Activities
    • Community Advisory Boards
  • Media
    • News
    • Newsletters
    • Press Releases
    • Annual Reports
    • Videos
  • Donate
Menu

Studies

Status:Ongoing

Find Out More
A Clinical Trial to Evaluate the Impact of Broadly Neutralizing Antibodies VRC01LS and 10-1074 on Maintenance of HIV Suppression in a Cohort of Early-Treated Children in Botswana (Dual bNAb Treatment in Children)/ Tatelo Study

Status:Ongoing

Find Out More
A cross-sectional evaluation of antibody responses to SARS-COV-2 vaccines

Status:Ongoing

Find Out More
Albuminuria Among Virally Suppressed HIV-infected Patients in Botswana: Longitudinal Changes and Association with Inflammation and ACEI/ARB Use in a Clinical Setting - Albuminuria Study

Status:Ongoing

Find Out More
Assessment of Proviral Reservoir: Synergistic combination of reporter cell assay and viral diversity

Status:Ongoing

Find Out More
Birth Outcomes Surveillance Study: Tsepamo Study

Status:Ongoing

Find Out More
Characterization of Anthracycline induced Cardiotoxicity Using Cardiac Magnetic Resonance in Botswana: A Prospective Observational study (Pelo Study)

Status:Ongoing

Find Out More
Contraceptives and Dolutegravir-based ART (CODA) Study

Status:Ongoing

Find Out More
Early Infant Treatment Study: A Clinical Trial of HIV Positive Infants in Botswana

Status:Ongoing

Find Out More
Exploring the Acceptability and Feasibility of COVID19 Testing among Truck Drivers in Botswana

Status:Ongoing

Find Out More
Feasibility and Accuracy of Nanosenor-based cancer diagnosis at the point of care (Chedza Study).

Status:Ongoing

Find Out More
FLOURISH: Following Longitudinal Outcomes to Understand, Report, Intervene and Sustain Health for Infants, Children, Adolescents who are HIV Exposed Uninfected

Status:Ongoing

Find Out More
HIV and Malignancy in Botswana: An observational Study of Medicine Toxicity of Concurrent Treatment and Clinical Outcomes (Thabatse Study)

Status:Ongoing

Find Out More
Human Papillomavirus (HPV) Cervical Cancer Screening Study

Status:Ongoing

Find Out More
Innovative HIV Testing Strategy for Middle-to-Upper Income Men in a Resource-Limited Setting

Status:Ongoing

Find Out More
Integrating Hypertension and Cardiovascular Diseases Care into Existing HIV Services Package in Botswana (InterCARE Study)

Status:Ongoing

Find Out More
International Sexual Health and Reproductive (ISHARE) Health Survey During COVID-19

Status:Ongoing

Find Out More
Karabo Study: Immune Correlates of Tuberculosis and non-Tuberculosis Infectious Morbidity in Southern African HIV- Exposed, Uninfected Infants

Status:Ongoing

Find Out More
Mitigating the impact of COVID-19 effects in adolescent reproductive health through self-testing: a mixed methods pilot study: “ICHEKE”

Status:Ongoing

Find Out More
Mopati: A Pilot HIV Treatment Partner Intervention in Botswana

Status:Ongoing

Find Out More
Neurodevelopment In HEU Children Exposed In Utero To Dolutegravir or Efavirenz and HIV-Unexposed Children (Motheo Study)

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Next page Next ›
  • Last page Last »

Media

The President of Botswana, His Excellency Dr. Mokgweetsi Eric Keabetswe Masisi and BHP Board Chairman Prof. Roger Shapiro
January 27, 2023
Botswana Government committed to strengthen BHP
Dr. Sikhulile Moyo
January 16, 2023
Dr. Moyo Recognised as one of the Most Influential Person in Africa
IMPRINT Launch
December 01, 2022
Botswana Harvard AIDS Institute Partnership (BHP) partners in a new NIHR-funded Global Health Research Group on HIV-associated Fungal Infections (IMPRINT)
Director of Science, Technology and Innovation-International Cooperation and Resources at the Ministry of Communications, Knowledge and Technology, Mr Ronnie Phutlhego.
November 30, 2022
BHP Helps Government To Apply For EDCTP Council Membership
View All

Footer Logo

 

Botswana Harvard AIDS Institute Partnership
Princess Marina Hospital
Plot No. 1836, Northring Road, Gaborone, Botswana
Email: info@bhp.org.bw
Tel: +267 3902671

  • f
  • t
  • l
  • y
  • Contact Us
  • Laboratory
  • Research Papers
  • Ongoing Studies

All Rights Reserved. Botswana Harvard AIDS Institute Partnership © 2022

Website Design and Development - MindQ

  • Home
  • About
    • Who We Are
    • History
    • Governance
      • Board of Members
      • Board of Directors
      • Executive Management
      • Senior Management
    • Principal Investigators
    • Our Capacity
    • Partners
    • Collaborators
    • Sponsors
    • Careers
    • Tenders
  • Research
    • Research Themes
    • Studies
      • Ongoing Studies
      • Completed Studies
    • Laboratory
    • Pharmacy
    • Clinical Research Sites
    • Data Management
    • Regulatory
    • Publications
  • Capacity Building
    • Training
    • Projects
  • Community Engagement
    • Community Engagement Activities
    • Community Advisory Boards
  • Media
    • News
    • Newsletters
    • Press Releases
    • Annual Reports
    • Videos
  • Donate